溴隐亭用于治疗围产期心肌病。 - Suppr

Suppr

超能文献

Bromocriptine for the treatment of peripartum cardiomyopathy.

作者信息

Elkayam Uri, Goland Sorel

出版信息

Circulation. 2010 Apr 6;121(13):1463-4. doi: 10.1161/CIR.0b013e3181db2f07. Epub 2010 Mar 22.

DOI:10.1161/CIR.0b013e3181db2f07

PMID:20308620

Abstract

摘要

相似文献

Bromocriptine for the treatment of peripartum cardiomyopathy.

Circulation. 2010 Apr 6;121(13):1463-4. doi: 10.1161/CIR.0b013e3181db2f07. Epub 2010 Mar 22.

The role of bromocriptine in peripartum cardiomyopathy.

Am J Obstet Gynecol. 2009 Aug;201(2):e13; author reply e13-4. doi: 10.1016/j.ajog.2009.01.036. Epub 2009 Mar 23.

Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.

Am J Obstet Gynecol. 2008 Oct;199(4):e5-6. doi: 10.1016/j.ajog.2008.06.051.

[Peripartum cardiomyopathy].

Ugeskr Laeger. 2009 Jan 5;171(1-2):53-5.

Recovery from peripartum cardiomyopathy after treatment with bromocriptine.

Eur J Heart Fail. 2008 Nov;10(11):1149-51. doi: 10.1016/j.ejheart.2008.09.001. Epub 2008 Oct 15.

Caution in the use of bromocriptine in peripartum cardiomyopathy.

J Am Coll Cardiol. 2008 May 27;51(21):2083; author reply 2083-4. doi: 10.1016/j.jacc.2008.02.054.

[Peripartumcardiomyopathy an often missed diagnosis].

Lakartidningen. 2013;110(23-24):1152-4.

Indication for bromocriptine in peripartum cardiomyopathy.

Eur J Heart Fail. 2009 Feb;11(2):223; author reply 223-4. doi: 10.1093/eurjhf/hfn038.

Peripartum cardiomyopathy: a challenge for cardiologist.

Rev Med Chir Soc Med Nat Iasi. 2013 Apr-Jun;117(2):358-67.

Circulating microparticles as indicators of peripartum cardiomyopathy.

Eur Heart J. 2012 Jun;33(12):1469-79. doi: 10.1093/eurheartj/ehr485. Epub 2012 Feb 3.

引用本文的文献

Meta-analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy.

ESC Heart Fail. 2025 Feb;12(1):304-315. doi: 10.1002/ehf2.15024. Epub 2024 Sep 18.

Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration.

J Cardiovasc Dev Dis. 2022 Jun 24;9(7):199. doi: 10.3390/jcdd9070199.

Cabergoline in the Treatment of Peripartum Cardiomyopathy.

Rev Bras Ginecol Obstet. 2016 Aug;38(8):423-4. doi: 10.1055/s-0036-1592295. Epub 2016 Sep 1.

Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine.

Case Rep Med. 2012;2012:476903. doi: 10.1155/2012/476903. Epub 2012 Nov 22.

Cardiomyopathy classification: ongoing debate in the genomics era.

Biochem Res Int. 2012;2012:796926. doi: 10.1155/2012/796926. Epub 2012 Aug 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Bromocriptine for the treatment of peripartum cardiomyopathy.

Circulation. 2010 Apr 6;121(13):1463-4. doi: 10.1161/CIR.0b013e3181db2f07. Epub 2010 Mar 22.

The role of bromocriptine in peripartum cardiomyopathy.

Am J Obstet Gynecol. 2009 Aug;201(2):e13; author reply e13-4. doi: 10.1016/j.ajog.2009.01.036. Epub 2009 Mar 23.

Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.

Am J Obstet Gynecol. 2008 Oct;199(4):e5-6. doi: 10.1016/j.ajog.2008.06.051.

[Peripartum cardiomyopathy].

Ugeskr Laeger. 2009 Jan 5;171(1-2):53-5.

Recovery from peripartum cardiomyopathy after treatment with bromocriptine.

Eur J Heart Fail. 2008 Nov;10(11):1149-51. doi: 10.1016/j.ejheart.2008.09.001. Epub 2008 Oct 15.

Caution in the use of bromocriptine in peripartum cardiomyopathy.

J Am Coll Cardiol. 2008 May 27;51(21):2083; author reply 2083-4. doi: 10.1016/j.jacc.2008.02.054.

[Peripartumcardiomyopathy an often missed diagnosis].

Lakartidningen. 2013;110(23-24):1152-4.

Indication for bromocriptine in peripartum cardiomyopathy.

Eur J Heart Fail. 2009 Feb;11(2):223; author reply 223-4. doi: 10.1093/eurjhf/hfn038.

Peripartum cardiomyopathy: a challenge for cardiologist.

Rev Med Chir Soc Med Nat Iasi. 2013 Apr-Jun;117(2):358-67.

Circulating microparticles as indicators of peripartum cardiomyopathy.

Eur Heart J. 2012 Jun;33(12):1469-79. doi: 10.1093/eurheartj/ehr485. Epub 2012 Feb 3.

引用本文的文献

Meta-analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy.

ESC Heart Fail. 2025 Feb;12(1):304-315. doi: 10.1002/ehf2.15024. Epub 2024 Sep 18.

Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration.

J Cardiovasc Dev Dis. 2022 Jun 24;9(7):199. doi: 10.3390/jcdd9070199.

Cabergoline in the Treatment of Peripartum Cardiomyopathy.

Rev Bras Ginecol Obstet. 2016 Aug;38(8):423-4. doi: 10.1055/s-0036-1592295. Epub 2016 Sep 1.

Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine.

Case Rep Med. 2012;2012:476903. doi: 10.1155/2012/476903. Epub 2012 Nov 22.

Cardiomyopathy classification: ongoing debate in the genomics era.

Biochem Res Int. 2012;2012:796926. doi: 10.1155/2012/796926. Epub 2012 Aug 8.